Stephen Basil Thomas, Director at Climb Bio, Inc. (CLYM), sold 100,000 shares at $7.00 ($700K) on 2026-02-25, disclosed to the SEC on 2026-02-27.
Open-market sale of $700k CLYM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.00 | 33,687 | $236K | 33.7% |
| 2 | $7.00 | 33,687 | $236K | 33.7% |
| 3 | $7.01 | 16,313 | $114K | 16.3% |
| 4 | $7.01 | 16,313 | $114K | 16.3% |
| Total | $7.00 avg | 100,000 | $700K | 100% |
| Filing → |